Electrocardiographic findings in systemic lupus erythematosus: Data from an international inception cohort

Arthritis Care and Research

Volumn 67, Issue 1, 2015, Pages 128-135

  Bourré Tessier, Josiane ^a   Urowitz, Murray B ^b   Clarke, Ann E ^c   Bernatsky, Sasha ^c   Krantz, Mori J ^d   Huynh, Thao ^e   Joseph, Lawrence ^e   Belisle, Patrick ^e   Bae, Sang Cheol ^f   Hanly, John G ^g   Wallace, Daniel J ^h   Gordon, Caroline ⁱ   Isenberg, David ^j   Rahman, Anisur ^j   Gladman, Dafna D ^b   Fortin, Paul R ^k   Merrill, Joan T ^l   Romero Diaz, Juanita ^m   Sanchez Guerrero, Jorge ^m   Fessler, Barri ⁿ   Alarcón, Graciela S ⁿ   Steinsson, Kristján ^o   Bruce, Ian N ^p   Ginzler, Ellen ^q   Dooley, Mary Anne ^r   Nived, Ola ^s   Sturfelt, Gunnar ^s   Kalunian, Kenneth ^t   Ramos Casals, Manuel ^u   Petri, Michelle ^v   Zoma, Asad ^w   Pineau, Christian A ^c   more..

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

^d UNIVERSITY OF COLORADO   (United States)

^e MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^f Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^g DALHOUSIE UNIVERSITY   (Canada)

^h CEDARS SINAI MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

^k LAVAL UNIVERSITY   (Canada)

^l OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^m INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

ⁿ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^o LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^p UNIVERSITY OF MANCHESTER   (United Kingdom)

^q SUNY DOWNSTATE MEDICAL CENTER   (United States)

^r UNIVERSITY OF NORTH CAROLINA   (United States)

^s LUND UNIVERSITY HOSPITAL   (Sweden)

^t UNIVERSITY OF CALIFORNIA   (United States)

^u Servicio de Enfermedades Autoinmunes   (Spain)

^v JOHNS HOPKINS UNIVERSITY   (United States)

^w NHS LANARKSHIRE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RO ANTIBODY;

ADULT; AMERICAN COLLEGE OF RHEUMATOLOGY DAMAGE INDEX; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; ECG ABNORMALITY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART REPOLARIZATION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE ASSESSMENT; PREVALENCE; QT DISPERSION; QT INTERVAL; REGISTER; SLEDAI; ST SEGMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; T WAVE; CLINICAL TRIAL; INTERNATIONAL COOPERATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; YOUNG ADULT;

ADULT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONALITY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; YOUNG ADULT;

EID: 84919966097     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22370     Document Type: Article

References (35)

1. Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol 1993;72:23B-5B.
2. Surawicz B. The QT interval and cardiac arrhythmias. Annu Rev Med 1987;38:81-90.
3. Bourre-Tessier J, Clarke AE, Huynh T, Bernatsky S, Joseph L, Belisle P, et al. Prolonged corrected QT interval in anti-Ro/ SSA-positive adults with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2011;63:1031-7.
4. Lazzerini PE, Acampa M, Guideri F, Capecchi L, Campanella V, Morozzi G, et al. Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases. Arthritis Rheum 2004;50:1248-52.
5. Lazzerini PE, Capecchi PL, Acampa M, Morozzi G, Bellisai F, Bacarelli MR, et al. Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity. Arthritis Care Res (Hoboken) 2011;63:1463-70.
6. Jaeggi ET, Silverman ED, Laskin C, Kingdom J, Golding F, Weber R. Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA and anti-La/SSB antibodies did not predict progressive heart block: a prospective observational study on the effects of maternal antibodies on 165 fetuses. J Am Coll Cardiol 2011;57:1487-92.
7. Gordon PA, Rosenthal E, Khamashta MA, Hughes GR. Absence of conduction defects in the electrocardiograms [correction of echocardiograms] of mothers with children with congenital complete heart block. J Rheumatol 2001;28:366-9.
8. Costedoat-Chalumeau N, Amoura Z, Hulot JS, Ghillani P, Lechat P, Funck-Brentano C, et al. Corrected QT interval in anti-SSA-positive adults with connective tissue disease: comment on the article by Lazzerini et al [letter]. Arthritis Rheum 2005;52:676-7.
9. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25: 1271-7.
10. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
11. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:809-13.
12. U.S. Food and Drug Administration. Guidance for industry: E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. Rockville (MD): Center for Drug Evaluation and Research; 2005.
13. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart 1920;7:353-70.
14. Krantz MJ, Lowery CM, Martell BA, Gourevitch MN, Arnsten JH. Effects of methadone on QT interval dispersion. Pharmacotherapy 2005;25:1523-9.
15. De Bacquer D, De Backer G, Kornitzer M. Prevalences of ECG findings in large population based samples of men and women. Heart 2000;84:625-33.
16. Mandell BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 1987;17:126-41.
17. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331-7.
18. Kautzner J, Malik M. QT interval dispersion and its clinical utility. Pacing Clin Electrophysiol 1997;20:2625-40.
19. Salles GF, Deccache W, Cardoso CR. Usefulness of QT-interval parameters for cardiovascular risk stratification in type 2 diabetic patients with arterial hypertension. J Hum Hypertens 2005;19:241-9.
20. Panoulas VF, Toms TE, Douglas K, Sandoo A, Metsios GS, Stavropoulos-Kalinoglou A, et al. Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden. Rheumatology (Oxford) 2014;53:131-7.
21. Mangoni A, Kinirons M, Swift C, Jackson S. Impact of age on QT interval and QT dispersion in healthy subjects: a regression analysis. Age Ageing 2003;32:326-31.
22. Festa A, D'Agostino R, Rautahariu P, Mykkanen L, Haffner SM. Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects. Am J Cardiol 2000;86:1117-22.
23. Brown DW, Giles WH, Greenlund KJ, Valdez R, Croft JB. Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration: results from the Third National Health and Nutrition Survey. J Cardiovasc Risk 2001;8:227-33.
24. Clancy RM, Neufing PJ, Zheng P, O'Mahony M, Nimmerjahn F, Gordon TP, et al. Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block. J Clin Invest 2006;116: 2413-22.
25. Schmidt KG, Ulmer HE, Silverman NH, Kleinman CS, Copel JA. Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J Am Coll Cardiol 1991;17:1360-6.
26. Nield LE, Silverman ED, Taylor GP, Smallhorn JF, Mullen JB, Silverman NH, et al. Maternal anti-Ro and anti-La antibodyassociated endocardial fibroelastosis. Circulation 2002;105: 843-8.
27. Buyon JP, Clancy RM. Neonatal lupus: basic research and clinical perspectives. Rheum Dis Clin North Am 2005;31: 299-313.
28. Xiao G, Hu K, Boutjdir M. Direct inhibition of expressed cardiac L- and T-type calcium channels by IgG from mothers whose children have congenital heart block. Circulation 2001; 103:1599-604.
29. Cimaz R, Meroni PL, Brucato A, Fesstova V, Panzeri P, Golene K, et al. Concomitant disappearance of electrocardiographic abnormalities and of acquired maternal autoantibodies during the first year of life in infants who had QT interval prolongation and anti-SSA/Ro positivity without congenital heart block at birth. Arthritis Rheum 2003;48:266-8.
30. Ravens U, Cerbai E. Role of potassium currents in cardiac arrhythmias. Europace 2008;10:1133-7.
31. Lazerrini PE, Capecchi PL, Guideri F, Bellisai F, Selvi E, Acampa M, et al. Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease. Am J Cardiol 2007;100:1029-34.
32. Yavuz B, Atalar E, Karadag O, Tulumen E, Ozer N, Akdogan A, et al. QT dispersion increases in patients with systemic lupus erythematous. Clin Rheumatol 2007;26:376-9.
33. Lazzerini PE, Capecchi PL, Acampa M, Selvi E, Guideri F, Bisogno S, et al. Arrhythmogenic effects of anti-Ro/SSA antibodies on the adult heart: more than expected? Autoimmun Rev 2009;9:40-4.
34. Johnson JN, Ackerman MJ. QTc: how long is too long? Br J Sports Med 2009;43:657-62.
35. Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2010;55:934-47.